Telithromycin CAS:191114-48-4

Telithromycin is indicated for the treatment of community-acquired respiratory tract infections, including acute exacerbations of chronic bronchitis, pneumonia, and sinusitis caused by susceptible organisms. It is available in oral formulations for convenient administration. The dosage and duration of telithromycin therapy depend on the type and severity of the infection, as well as individual patient factors. Patients are advised to adhere to the prescribed regimen and complete the full course of treatment to ensure successful eradication of the infection and reduce the risk of antibiotic resistance. Common side effects of telithromycin may include gastrointestinal disturbances, headache, and taste disturbances. Serious adverse effects such as hepatotoxicity and visual disturbances have been reported, necessitating caution and monitoring during treatment. Patients experiencing unusual symptoms should seek medical attention promptly. Telithromycin should be used with caution in patients with pre-existing liver or kidney impairment and in those taking medications known to prolong the QT interval. Consultation with healthcare providers is recommended for personalized treatment recommendations and guidance on managing side effects to ensure safe and effective use of telithromycin in respiratory tract infections.